MD Medical Group Investments Plc EBIT

The latest EBIT for MDMG.L is $6.3B as of December 2019. That compares with $5.6B in the prior-year period — up 13.4% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside MD Medical Group Investments Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, MDMG.L's EBIT moved from $5.6B to $6.3B — a 13.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MD Medical Group Investments Plc's operating scale or balance-sheet position.

Against its sector companies, MDMG.L currently prints $6.3B for EBIT, while the sector average sits near $2.6T. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at MD Medical Group Investments Plc's growth, margins, and balance sheet.

A EBIT figure of $6.3B for MDMG.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting MDMG.L's EBIT ($6.3B), review year-over-year change from $5.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.